Stay updated on ADMEC-O: Clinical Trial of Immunotherapy vs Observation
Sign up to get notified when there's something new on the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page.

Latest updates to the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a new 'Locations' section listing North Rhine-Westphalia and updated the page revision to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check43 days agoChange DetectedA new revision label (v3.3.2) is shown, replacing the previous v3.3.1. No other content or data on the page appears to be altered.SummaryDifference0.0%

- Check50 days agoChange DetectedThe Publications section now notes that publications are automatically filled from PubMed and may not be about the study, and the page shows a revised version label: Revision: v3.3.1.SummaryDifference0.1%

- Check57 days agoChange DetectedThe government funding/operating status banner was removed from the page. This banner previously informed users about potential delays and NIH operations status, but its removal does not affect the trial details or eligibility criteria.SummaryDifference0.3%

- Check71 days agoChange DetectedNo significant changes to the study details were detected; the page continues to present the ADMEC-O trial with nivolumab vs observation, including its design, endpoints, and eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check100 days agoChange DetectedUpdated to v3.2.0 with a government operating-status notice; a resource entry (Cutaneous neuroendocrine carcinoma) was removed and revision tag shows v3.1.0 previously.SummaryDifference3%

Stay in the know with updates to ADMEC-O: Clinical Trial of Immunotherapy vs Observation
Enter your email address, and we'll notify you when there's something new on the ADMEC-O: Clinical Trial of Immunotherapy vs Observation page.